This is the main reason for today's sell off, imo.
I just woke up and noticed you're still stupid as ever. When did I ever say I was German? Read with understanding you numb nut. I said I speak German. FYI, I am not German. Still LMFAO at little Stevie. BTW, yes SQNM is working for me and will work for me in the future. You won't get it because you can't even read with understanding.
Epigenomics is not, never has been, and never will be, a serious competitor to EXAS for reasons discussed here many times for a year or two. Same old marker they've been struggling with for years. They released results of a big trial last Jan or so, definitively establishing they are at best mediocre (no pre-cancer, CRC comparable to FIT for much higher cost). Their stock fell 40% on the news and didn't recover. (What value they retained was from other products IMO.) Adding a small, imprecise study (easy to manipulate) using the same test is a non-event. CRC performance numbers without providing what cancers stages is utterly meaningless, especially from a company with a rich history of spreading BS of exactly this type. Pre-cancer and stage 1 performance, confirmed by a reputable independent party, is what matters. Tomorrow we'll see EXAS has it. EPI never will.
I went through all of this again recently and repeatedly. E.g.,
Newbies can search this board for blood test or sept9 or septin. Lots of info.
no kidding! you don't have to be a scientist to know that when you see the results it provides NO COMFORT whatsoever.
Patient: What are the results?
Doctor: Negative. But the blood test only detect much later stages of cancer. You'll need a colonosopy to be sure. Please schedule one with the front desk.
It should be a dead giveaway when they don't break it down by cancer stages. Presumably they would crow about it if it detected a lot of Stage 1 cancers. The fact that they didn't speaks volumes. I am amazed that anyone--even Wall Street traders--still takes this company seriously. BTW the guy who headed the large failed Epigenomics colon cancer screening trial just joined another basket-case company, Aspen Biosciences (APPY). Good luck to him in trying to salvage their snake-bitten appendicitis screening test.
"What numbers are expected from EXAS tomorrow? What will be considered acceptable for the stock to move up?" -Olesno the German brain surgeon-
Yeah you're long in a company you know nothing about? Great. I'm selling first thing in the morning.
You must not be too smart to try to point it out to me that in Germany it is the 28th ha, ha, ha. No kidding...LOL. Another reason you're not too smart is......., you think I want to bash EXAS? How do you know I am not long? I tell you a little secret, I am...., and I probably own more shares than you. I am long in SQNM as well, but that's too complicated for you to understand. Still LMFAO. BTW, I used to live in Germany and I speak German. Can you find Germany on the map? I didn't think so....